
A New Tool to Measure Quality of Life for Swedish Teens with Type 1 Diabetes
Researchers have validated a questionnaire designed to help healthcare providers understand how type 1 diabetes affects the emotional, social, and physical well-being of young people. The tool is now available in Swedish.
Evidence label explains the kind of source behind this article (for example peer-reviewed literature vs community video). It is not medical advice.
Key takeaways
- The Mind Youth Questionnaire (My-Q) is a validated survey that measures nine different aspects of quality of life for teens with type 1 diabetes, including social impact, family relationships, diabetes control, worries, treatment satisfaction, body image, stigma, and mood.
- Swedish healthcare providers can now use this tool to better understand how diabetes affects their young patients beyond just blood sugar numbers.
- The questionnaire was tested with 166 Swedish-speaking youth ages 10-19 and showed it reliably measures what it's designed to measure.
- This is the first Swedish version of the My-Q; versions already exist in Dutch, English, and Spanish.
Why Measuring Quality of Life Matters
Living with type 1 diabetes involves far more than managing blood sugar. Young people navigate school, friendships, family relationships, and their own feelings about their condition—all while managing daily insulin and monitoring. Healthcare providers need ways to understand how diabetes affects all these areas of a teen's life, not just their medical numbers.
The Mind Youth Questionnaire (My-Q) was created to help healthcare teams get a fuller picture. By asking teens about their experiences, worries, relationships, and how they feel about their bodies and their treatment, the questionnaire can reveal where young people might need extra support.
What the Swedish Validation Study Found
Researchers translated and tested the My-Q with 166 Swedish-speaking youth ages 10-19 with type 1 diabetes. The process followed international translation guidelines to ensure the questions were culturally appropriate and clearly understood.
The final Swedish version includes 38 items organized into nine categories: social impact, parent relationships, diabetes control perceptions, responsibilities, worries, treatment satisfaction, body image and eating behavior, stigma, and mood. The researchers also included three questions specifically about stigma, recognizing that discrimination or shame can significantly affect young people's well-being.
Statistical testing showed the questionnaire performs reliably—it consistently measures what it's intended to measure across all nine areas. Healthcare providers can trust the results when using this tool with Swedish-speaking teens.
How This Tool Can Help Clinics
With a validated Swedish version now available, diabetes clinics in Sweden and other Swedish-speaking regions have a standardized way to assess quality of life. Instead of relying only on clinical measurements like A1C or glucose readings, providers can use the My-Q to start conversations about how teens are really doing emotionally and socially.
These conversations can help identify teens who are struggling with specific areas—such as worry about their condition, body image concerns, or feeling stigmatized—so healthcare teams can connect them with the right resources or support.
A Growing Toolkit
The My-Q now exists in multiple languages: Dutch, English, Spanish, and Swedish. This expansion makes it possible for more healthcare systems worldwide to measure and support the quality of life of young people with type 1 diabetes in a consistent, evidence-based way.
Evidence label
Source: Journal of patient-reported outcomes. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.
Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.
Related reading
More evidence-labeled coverage across the Type1Cure library.
- Living With T1DCorrection to "The Use of an Automated Insulin Delivery System Is Associated With a Reduction in Diabetes Distress and Improvement in Quality of Life in People With Type 1 Diabetes".PubMed indexed literature
- Living With T1DA New Class of Biologics Could Change How We Treat Type 1 DiabetesPubMed indexed literature
- Living With T1DMenopause and Type 1 Diabetes: What Women Need to KnowPubMed indexed literature
- Living With T1DThe Promise and Challenge of Oral Insulin: Where the Research StandsPubMed indexed literature
- Living With T1DYour Glucose Range May Not Be the Guideline Range—And That's Worth UnderstandingPubMed indexed literature
- Living With T1DMetformin in Pregnancy With Type 1 Diabetes: What Early Data ShowsPubMed indexed literature